These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28845468)

  • 1. Evolutionary Nephrology.
    Chevalier RL
    Kidney Int Rep; 2017 May; 2(3):302-317. PubMed ID: 28845468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution, kidney development, and chronic kidney disease.
    Chevalier RL
    Semin Cell Dev Biol; 2019 Jul; 91():119-131. PubMed ID: 29857053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioenergetic Evolution Explains Prevalence of Low Nephron Number at Birth: Risk Factor for CKD.
    Chevalier RL
    Kidney360; 2020 Aug; 1(8):863-879. PubMed ID: 35372951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetics: the evolutionary basis of progressive kidney disease.
    Chevalier RL
    Physiol Rev; 2023 Oct; 103(4):2451-2506. PubMed ID: 36996412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is chronic kidney disease progressive? Evolutionary adaptations and maladaptations.
    Chevalier RL
    Am J Physiol Renal Physiol; 2023 Nov; 325(5):F595-F617. PubMed ID: 37675460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs.
    Luyckx VA; Chevalier RL
    Exp Physiol; 2022 May; 107(5):410-414. PubMed ID: 35037332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical consequences of developmental programming of low nephron number.
    Luyckx VA; Brenner BM
    Anat Rec (Hoboken); 2020 Oct; 303(10):2613-2631. PubMed ID: 31587509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary trade-offs in kidney injury and repair.
    Lei Y; Anders HJ
    Histol Histopathol; 2017 Nov; 32(11):1099-1113. PubMed ID: 28481398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low birth weight, nephron number, and kidney disease.
    Luyckx VA; Brenner BM
    Kidney Int Suppl; 2005 Aug; (97):S68-77. PubMed ID: 16014104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evo-devo perspectives on cancer.
    Nedelcu AM
    Essays Biochem; 2022 Dec; 66(6):797-815. PubMed ID: 36250956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A way forward with eco evo devo: an extended theory of resource polymorphism with postglacial fishes as model systems.
    Skúlason S; Parsons KJ; Svanbäck R; Räsänen K; Ferguson MM; Adams CE; Amundsen PA; Bartels P; Bean CW; Boughman JW; Englund G; Guðbrandsson J; Hooker OE; Hudson AG; Kahilainen KK; Knudsen R; Kristjánsson BK; Leblanc CA; Jónsson Z; Öhlund G; Smith C; Snorrason SS
    Biol Rev Camb Philos Soc; 2019 Oct; 94(5):1786-1808. PubMed ID: 31215138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where is, in 2017, the evo in evo-devo (evolutionary developmental biology)?
    Diogo R
    J Exp Zool B Mol Dev Evol; 2018 Jan; 330(1):15-22. PubMed ID: 29393575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kowalevsky, comparative evolutionary embryology, and the intellectual lineage of evo-devo.
    Raff RA; Love AC
    J Exp Zool B Mol Dev Evol; 2004 Jan; 302(1):19-34. PubMed ID: 14760652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How evolutionary principles improve the understanding of human health and disease.
    Gluckman PD; Low FM; Buklijas T; Hanson MA; Beedle AS
    Evol Appl; 2011 Mar; 4(2):249-63. PubMed ID: 25567971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low nephron endowment increases susceptibility to renal stress and chronic kidney disease.
    Good PI; Li L; Hurst HA; Serrano Herrera I; Xu K; Rao M; Bateman DA; Al-Awqati Q; D'Agati VD; Costantini F; Lin F
    JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36626229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron mass as a risk factor for progression of renal disease.
    Brenner BM; Mackenzie HS
    Kidney Int Suppl; 1997 Dec; 63():S124-7. PubMed ID: 9407439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evolutionary medicine approach to understanding factors that contribute to chronic obstructive pulmonary disease.
    Aoshiba K; Tsuji T; Itoh M; Yamaguchi K; Nakamura H
    Respiration; 2015; 89(3):243-52. PubMed ID: 25677028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low nephron number and its clinical consequences.
    Luyckx VA; Shukha K; Brenner BM
    Rambam Maimonides Med J; 2011 Oct; 2(4):e0061. PubMed ID: 23908819
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.